Anti-apoptotic and Immunomodulatory Effect of CB2 Agonist, JWH133, in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy
Introduction: Neonatal HIE is associated with high morbidity and mortality. Current research, is focused on developing alternative treatments to therapeutic hypothermia for treatment of HIE. The endocannabinoid system is known to be influential in neuronal protection. Activation of brain CB2 recepto...
Main Authors: | Bhavna Gupta, Mary G. Hornick, Seema Briyal, Ramona Donovan, Preetha Prazad, Anil Gulati |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2020.00065/full |
Similar Items
-
Hypopituitarism: A Sequela of Severe Hypoxic Encephalopathy
by: Deng-Huang Su
Published: (2006-01-01) -
Diabetes Insipidus with Hypoxic Encephalopathy
by: J Gordon Millichap
Published: (1996-05-01) -
Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19
by: Niraj Kumar Jha, et al.
Published: (2021-08-01) -
Hypoxic-Ischemic Encephalopathy and Infantile Spasms
by: J Gordon Millichap
Published: (2014-01-01) -
Evaluation of 80 Term Neonates with Hypoxic Ischemic Encephalopathy
by: Selahattin Katar, et al.
Published: (2007-01-01)